UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Open-label, phase II, multicenter study of lasofoxifene plus abemaciclib for treating women with metastatic ER+/HER2− breast cancer and an ESR1 mutation after disease progression on prior therapies: ELAINE 2

Annals of oncology, 2023-12, Vol.34 (12), p.1131-1140

2023

Volltextzugriff (PDF)

Abstract P3-06-16: The pattern of alpha- and beta- adrenergic receptor expression impacts breast cancer outcome

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P3-P3-06-16

2019

Volltextzugriff (PDF)

Abstract P1-09-09: Octogenerian breast cancer was associated with higher infiltration of M2 macrophages and tregs and worse disease free survival

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P1-P1-09-09

2019

Volltextzugriff (PDF)

Abstract P4-06-05: PanCancer profiling reveals population difference in breast cancer immune microenvironment

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P4-P4-06-05

2019

Volltextzugriff (PDF)

Primary and secondary breast angiosarcoma: single center report and a meta-analysis

Breast cancer research and treatment, 2019-12, Vol.178 (3), p.523-533

2019

Volltextzugriff (PDF)

Contribution of Immune Cells to Glucocorticoid Receptor Expression in Breast Cancer

International journal of molecular sciences, 2020-06, Vol.21 (13), p.4635

2020

Volltextzugriff (PDF)

Increasing inclusion and equity for Black women in breast cancer clinical trials

Clinical advances in hematology & oncology, 2024-05, Vol.22 (4), p.175-182

2024

Volltextzugriff (PDF)

Abstract P2-10-03: Detrimental impact of T-regulatory cells on outcome of breast cancer in African American population

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P2-P2-10-03

2020

Volltextzugriff (PDF)

Mutations in Homologous Recombination Genes and Loss of Heterozygosity Status in Advanced-Stage Breast Carcinoma

Cancers, 2023-04, Vol.15 (9), p.2524

2023

Volltextzugriff (PDF)

Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer

Breast cancer research and treatment, 2018-01, Vol.167 (1), p.89-99

2018

Volltextzugriff (PDF)

Racial disparity in breast cancer immune microenvironment

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.1081-1081

2018

Volltextzugriff (PDF)

Plumbagin inhibits tumorigenesis and angiogenesis of ovarian cancer cells in vivo

International journal of cancer, 2013-03, Vol.132 (5), p.1201-1212

2013

Volltextzugriff (PDF)

A phase I/II study of preoperative letrozole, everolimus, and carotuximab in stage 2 and 3 hormone receptor-positive and Her2-negative breast cancer

Breast cancer research and treatment, 2023-04, Vol.198 (2), p.217-229

2023

Volltextzugriff (PDF)

GAIP interacting protein C-terminus regulates autophagy and exosome biogenesis of pancreatic cancer through metabolic pathways

PloS one, 2014-12, Vol.9 (12), p.e114409

2014

Volltextzugriff (PDF)

Breast Tumor Microenvironment in Black Women: A Distinct Signature of CD8+ T-Cell Exhaustion

JNCI : Journal of the National Cancer Institute, 2021-08, Vol.113 (8), p.1036-1043

2021

Volltextzugriff (PDF)

Abstract P4-05-16: Immune landscape of glucocorticoid receptor high breast cancer

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P4-P4-05-16

2020

Volltextzugriff (PDF)

Older Patients with NPM1 Mutated AML Have Distinctive Genomic Mutation Landscape Associated with Enrichment in Immunosuppressive Gene Signature

Blood, 2019-11, Vol.134 (Supplement_1), p.1402-1402

2019

Volltextzugriff (PDF)

Effect of prior treatments on post-CDK 4/6 inhibitor survival in hormone receptor-positive breast cancer

Breast cancer research and treatment, 2023-02, Vol.197 (3), p.673-681

2023

Volltextzugriff (PDF)

The tumor microenvironment in EGFR-driven loco-regional lung adenocarcinoma can predict higher risk of recurrence

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.8521-8521

2019

Volltextzugriff (PDF)

Immune landscape of the tumor microenvironment to predict prognosis and DNA mutations in patients with lung adenocarcinoma

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.8544-8544

2019

Volltextzugriff (PDF)

Risk score and prognosis modeling based on mRNA expressivity in the tumor microenvironment of GI cancers

Journal of clinical oncology, 2019-02, Vol.37 (4_suppl), p.608-608

2019

Volltextzugriff (PDF)

LAG3 Promotes Acute Myeloid Leukemia-Induced Immune Suppression

Blood, 2018-11, Vol.132 (Supplement 1), p.2414-2414

2018

Volltextzugriff (PDF)

472 Utility of [89Zr]Trastuzumab-PET/MRI Imaging for Quantitative Assessment of Tumor Heterogeneity In HER2+ Breast Cancer

Journal of clinical and translational science, 2024-04, Vol.8 (s1), p.139-139

2024

Volltextzugriff (PDF)

Abstract PS18-18: Microsatellite instability high (MSI-H) detection utilizing targeted plasma based genotyping in metastatic breast cancer

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS18-18-PS18-18

2021

Volltextzugriff (PDF)

Abstract 136: Modeling of prognostication and immune profiling, based on genomic analysis in the tumor microenvironment of pancreatic adenocarcinoma via machine learning

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.136-136

2019

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(48)

Sprache

Englisch
(48)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Open-label, phase II, multicenter study of lasofoxifene plus abemaciclib for treating women with metastatic ER+/HER2− breast cancer and an ESR1 mutation after disease progression on prior therapies: ELAINE 2

Abstract P3-06-16: The pattern of alpha- and beta- adrenergic receptor expression impacts breast cancer outcome

Abstract P1-09-09: Octogenerian breast cancer was associated with higher infiltration of M2 macrophages and tregs and worse disease free survival

Abstract P4-06-05: PanCancer profiling reveals population difference in breast cancer immune microenvironment

Primary and secondary breast angiosarcoma: single center report and a meta-analysis

Contribution of Immune Cells to Glucocorticoid Receptor Expression in Breast Cancer

Increasing inclusion and equity for Black women in breast cancer clinical trials

Abstract P2-10-03: Detrimental impact of T-regulatory cells on outcome of breast cancer in African American population

Mutations in Homologous Recombination Genes and Loss of Heterozygosity Status in Advanced-Stage Breast Carcinoma

Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer

Racial disparity in breast cancer immune microenvironment

Plumbagin inhibits tumorigenesis and angiogenesis of ovarian cancer cells in vivo

A phase I/II study of preoperative letrozole, everolimus, and carotuximab in stage 2 and 3 hormone receptor-positive and Her2-negative breast cancer

GAIP interacting protein C-terminus regulates autophagy and exosome biogenesis of pancreatic cancer through metabolic pathways

Breast Tumor Microenvironment in Black Women: A Distinct Signature of CD8+ T-Cell Exhaustion

Abstract P4-05-16: Immune landscape of glucocorticoid receptor high breast cancer

Older Patients with NPM1 Mutated AML Have Distinctive Genomic Mutation Landscape Associated with Enrichment in Immunosuppressive Gene Signature

Effect of prior treatments on post-CDK 4/6 inhibitor survival in hormone receptor-positive breast cancer

The tumor microenvironment in EGFR-driven loco-regional lung adenocarcinoma can predict higher risk of recurrence

Immune landscape of the tumor microenvironment to predict prognosis and DNA mutations in patients with lung adenocarcinoma

Risk score and prognosis modeling based on mRNA expressivity in the tumor microenvironment of GI cancers

LAG3 Promotes Acute Myeloid Leukemia-Induced Immune Suppression

472 Utility of [89Zr]Trastuzumab-PET/MRI Imaging for Quantitative Assessment of Tumor Heterogeneity In HER2+ Breast Cancer

Abstract PS18-18: Microsatellite instability high (MSI-H) detection utilizing targeted plasma based genotyping in metastatic breast cancer

Abstract 136: Modeling of prognostication and immune profiling, based on genomic analysis in the tumor microenvironment of pancreatic adenocarcinoma via machine learning

Suchergebnisse filtern